New window on fibrosis

cancer cell
Credit: CC0 Public Domain

DDR1 is a receptor tyrosine kinase (RTK)—a cell surface receptor—that regulates multiple functions including the maintenance of the normal structure of tissues, but which also contributes to pathological conditions including cancer, inflammation and fibrosis.

In the kidney, upregulation of DDR1 expression contributes to inflammation and progression of fibrotic responses that can damage the kidney. How it does this has been unclear.

Now, in a report in the Journal of the American Society of Nephrology, Ambra Pozzi, Ph.D., and colleagues demonstrate that, like other RTKs, activated DDR1 can translocate to the nucleus of the cell, where it acts as a co-transcription factor.

In the nucleus DDR1 regulates the transcription of pro-fibrotic molecules including collagen IV. A structural protein, collagen IV is a component of the extracellular matrix. Together with collagen I, collagen IV is upregulated in fibrosis.

This previously unrecognized nuclear role of DDR1 opens unanticipated therapeutic options for the treatment of fibrotic diseases, the researchers concluded.

More information: Manuel Chiusa et al. The Extracellular Matrix Receptor Discoidin Domain Receptor 1 Regulates Collagen Transcription by Translocating to the Nucleus, Journal of the American Society of Nephrology (2019). DOI: 10.1681/ASN.2018111160

Citation: New window on fibrosis (2019, August 9) retrieved 28 February 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Scientists report new approach to reduce or prevent renal fibrosis


Feedback to editors